Skip to main content

This website is intended exclusively for the Registered Medical Practitioners in India.

Home | go to homepage
SCIENCE
  • SCIENCE
  • CNS
  • Diabetes
  • Kidney Transplant
  • Otolaryngeal Disorders
  • Respiratory Diseases
  • Thrombosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • CNS
  • Diabetes
  • Kidney Transplant
  • Otolaryngeal Disorders
  • Respiratory Diseases
PRODUCTS
  • PRODUCTS
  • Allegra® Group
  • Amaryl® & Combinations
  • Apidra®
  • Cardace®
  • Clexane®
  • Frisium®
  • Lantus®
  • Synvisc-One™
  • Targocid®
  • Thymoglobuline®
  • Toujeo®
  • Valparin®
  • Vinlep™
  • Vinlep™ Suspension
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • CNS
  • Diabetes
  • Kidney Transplant
  • Otolaryngeal Disorders
  • Respiratory Diseases
  • Thrombosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • CNS
  • Diabetes
  • Kidney Transplant
  • Otolaryngeal Disorders
  • Respiratory Diseases
PRODUCTS
  • PRODUCTS
  • Allegra® Group
  • Amaryl® & Combinations
  • Apidra®
  • Cardace®
  • Clexane®
  • Frisium®
  • Lantus®
  • Synvisc-One™
  • Targocid®
  • Thymoglobuline®
  • Toujeo®
  • Valparin®
  • Vinlep™
  • Vinlep™ Suspension
  • Log in
  • Register
  • Search
    • Home
    • Products
    • Cardace®
    • Cutting-Edge Apidra
    Filters

    Products
    Kidney Transplantation
    Immunology
    Transplant Nephrology
    Thrombosis
    Nephrology
    Apidra
    Lantus
    Toujeo
    Amaryl Combinations
    CNS
    Cardace
    Type of Content
    Watch
    Listen
    Read
    0:17:10

    Antibody mediated rejection - Diagnosis and management: Dr. (Prof.) Dinesh Khullar

    0:17:20

    Post transplant infections and its management: Dr. Umapati N. Hedge

    0:02:00

    COVID-19 pandemic research opportunities in India

    0:02:00

    Relevance of donor specific antibody monitoring after kidney transplantation

    0:02:00

    Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study

    0:10:55

    Are we oblivious to the second leading cause of mortality in cancer? Episode 3: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)

    0:10:55

    Are we oblivious to the second leading cause of mortality in cancer. Episode 2: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)

    0:13:29

    Are we oblivious to the second leading cause of mortality in cancer. Episode 1: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)

    0:02:14

    A Smart companion on the journey with diabetes

    0:14:48

    Implementing thromboprophylaxis in surgical patients

    0:15:05

    PE case reports

    0:37:00

    3 T approach for PE management

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    Home | go to homepage

    Sanofi 2021-2022 - All rights reserved

    • Privacy Policy
    • Contact Us
    • Legal Notice
    • Sitemap
    • Cookie Policy
    • Sanofi India

    This website is intended exclusively for Registered Medical Practitioners in India.

    Please select the tab below to continue.